I think the whole issue of coordinated labelling is going to be critical. It's true not only on the U.S. side moving ahead with GMO labelling but there's also an issue arising in Canada with Health Canada looking at front-of-package labelling, which is creating some concerns for Canada processors.
I think it becomes one of those things, when you're moving ahead with labelling, that you have to really take a look at what's being accepted in the international markets you're trading into but at the same time ensure that it doesn't become a non-tariff barrier. I think in Canada and many countries labelling has always been done to identify a potential food health issue as opposed to a perception issue.
I was recently in the United States and met with a number of farm groups there, and they're basically in the same place we are. They want the labelling to be evidence and science-based. That is why I think it's really important in trade agreements to make sure that those types of issues are addressed. It's not just about tariffs anymore. It's about a number of these different issues and a change in one jurisdiction could really drive extra cost into the system and create a competitive disadvantage for Canadians.